Copyright Reports & Markets. All rights reserved.

Global Pruritus Therapeutics Market Growth (Status and Outlook) 2019-2024

Buy now

Table of Contents

    2019-2024 Global Pruritus Therapeutics Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Pruritus Therapeutics Market Size 2014-2024
        • 2.1.2 Pruritus Therapeutics Market Size CAGR by Region
      • 2.2 Pruritus Therapeutics Segment by Type
        • 2.2.1 Antihistamines
        • 2.2.2 Corticosteroids
        • 2.2.3 Calcineurin Inhibitors
        • 2.2.4 Other
      • 2.3 Pruritus Therapeutics Market Size by Type
        • 2.3.1 Global Pruritus Therapeutics Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Pruritus Therapeutics Market Size Growth Rate by Type (2014-2019)
      • 2.4 Pruritus Therapeutics Segment by Application
        • 2.4.1 External Use
        • 2.4.2 Oral
        • 2.4.3 Injection
      • 2.5 Pruritus Therapeutics Market Size by Application
        • 2.5.1 Global Pruritus Therapeutics Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Pruritus Therapeutics Market Size Growth Rate by Application (2014-2019)

      3 Global Pruritus Therapeutics by Players

      • 3.1 Global Pruritus Therapeutics Market Size Market Share by Players
        • 3.1.1 Global Pruritus Therapeutics Market Size by Players (2017-2019)
        • 3.1.2 Global Pruritus Therapeutics Market Size Market Share by Players (2017-2019)
      • 3.2 Global Pruritus Therapeutics Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Pruritus Therapeutics by Regions

      • 4.1 Pruritus Therapeutics Market Size by Regions
      • 4.2 Americas Pruritus Therapeutics Market Size Growth
      • 4.3 APAC Pruritus Therapeutics Market Size Growth
      • 4.4 Europe Pruritus Therapeutics Market Size Growth
      • 4.5 Middle East & Africa Pruritus Therapeutics Market Size Growth

      5 Americas

      • 5.1 Americas Pruritus Therapeutics Market Size by Countries
      • 5.2 Americas Pruritus Therapeutics Market Size by Type
      • 5.3 Americas Pruritus Therapeutics Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Pruritus Therapeutics Market Size by Countries
      • 6.2 APAC Pruritus Therapeutics Market Size by Type
      • 6.3 APAC Pruritus Therapeutics Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Pruritus Therapeutics by Countries
      • 7.2 Europe Pruritus Therapeutics Market Size by Type
      • 7.3 Europe Pruritus Therapeutics Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Pruritus Therapeutics by Countries
      • 8.2 Middle East & Africa Pruritus Therapeutics Market Size by Type
      • 8.3 Middle East & Africa Pruritus Therapeutics Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Pruritus Therapeutics Market Forecast

      • 10.1 Global Pruritus Therapeutics Market Size Forecast (2019-2024)
      • 10.2 Global Pruritus Therapeutics Forecast by Regions
        • 10.2.1 Global Pruritus Therapeutics Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Pruritus Therapeutics Forecast by Type
      • 10.8 Global Pruritus Therapeutics Forecast by Application

      11 Key Players Analysis

      • 11.1 J&J
        • 11.1.1 Company Details
        • 11.1.2 Pruritus Therapeutics Product Offered
        • 11.1.3 J&J Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 J&J News
      • 11.2 Abbott
        • 11.2.1 Company Details
        • 11.2.2 Pruritus Therapeutics Product Offered
        • 11.2.3 Abbott Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Abbott News
      • 11.3 Amgen
        • 11.3.1 Company Details
        • 11.3.2 Pruritus Therapeutics Product Offered
        • 11.3.3 Amgen Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Amgen News
      • 11.4 LEO Pharma
        • 11.4.1 Company Details
        • 11.4.2 Pruritus Therapeutics Product Offered
        • 11.4.3 LEO Pharma Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 LEO Pharma News
      • 11.5 Novartis
        • 11.5.1 Company Details
        • 11.5.2 Pruritus Therapeutics Product Offered
        • 11.5.3 Novartis Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Novartis News
      • 11.6 Bayer
        • 11.6.1 Company Details
        • 11.6.2 Pruritus Therapeutics Product Offered
        • 11.6.3 Bayer Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Bayer News
      • 11.7 Pfizer
        • 11.7.1 Company Details
        • 11.7.2 Pruritus Therapeutics Product Offered
        • 11.7.3 Pfizer Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Pfizer News
      • 11.8 UCB Pharma
        • 11.8.1 Company Details
        • 11.8.2 Pruritus Therapeutics Product Offered
        • 11.8.3 UCB Pharma Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 UCB Pharma News
      • 11.9 GlaxoSmithKline
        • 11.9.1 Company Details
        • 11.9.2 Pruritus Therapeutics Product Offered
        • 11.9.3 GlaxoSmithKline Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 GlaxoSmithKline News
      • 11.10 Galderma
        • 11.10.1 Company Details
        • 11.10.2 Pruritus Therapeutics Product Offered
        • 11.10.3 Galderma Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.10.4 Main Business Overview
        • 11.10.5 Galderma News
      • 11.11 Huapont

      12 Research Findings and Conclusion

      Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
      Skin disease is the fourth leading cause of nonfatal disease burden. Skin diseases include eczema, psoriasis, acne vulgaris, pruritus, alopecia areata, decubitus ulcer, urticaria, scabies, fungal skin diseases, impetigo, abscess, and other bacterial skin diseases, cellulitis, viral warts, molluscum contagiosum, and non-melanoma skin cancer. Among these types, fungal skin diseases and pruritus were in the top 10 most prevalent diseases worldwide in 2010. Thus pruritus therapeutics market is growing with rising prevalence of skin diseases. Moreover, patent expiration of dermatitis drugs and the introduction of new products are also responsible for the growth of pruritus therapeutics market.
      The classification of Pruritus Therapeutics includes Corticosteroids, Antihistamines, Calcineurin Inhibitors and other. The proportion of Antihistamines in 2016 is about 21.6%, and the proportion of Corticosteroids is about 22.9%.
      North America is the largest consumption place, with a revenue market share nearly 43.4% in 2016. Following North America, Europe is the second largest consumption place with the revenue market share of 27.3%.

      According to this study, over the next five years the Pruritus Therapeutics market will register a 4.9% CAGR in terms of revenue, the global market size will reach US$ 15000 million by 2024, from US$ 11300 million in 2019. In particular, this report presents the global revenue market share of key companies in Pruritus Therapeutics business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares and growth opportunities of Pruritus Therapeutics market by product type, application, key companies and key regions.

      This study considers the Pruritus Therapeutics value generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
      Antihistamines
      Corticosteroids
      Other
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
      External Use
      Oral
      Injection

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      J&J
      Abbott
      Amgen
      LEO Pharma
      Novartis
      Bayer
      Pfizer
      UCB Pharma
      GlaxoSmithKline
      Galderma
      Huapont

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Pruritus Therapeutics market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Pruritus Therapeutics market by identifying its various subsegments.
      Focuses on the key global Pruritus Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Pruritus Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the size of Pruritus Therapeutics submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now